Encompass Health Corporation (EHC) reported fourth-quarter 2025 results. Total revenue was $3.09 billion, up 119.87% year-over-year and well above the consensus estimate of $1.56 billion.
Key profitability and per-share results:
Balance sheet and cash-flow highlights:
Shares of EHC moved 20.53% since market close following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Encompass Health Corporation Insider Trading Activity
Encompass Health Corporation insiders have traded $EHC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EHC stock by insiders over the last 6 months:
- PATRICK WILLIAM TUER (EVP, Chief Operating Officer) sold 1,020 shares for an estimated $126,061
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Encompass Health Corporation Hedge Fund Activity
We have seen 256 institutional investors add shares of Encompass Health Corporation stock to their portfolio, and 329 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,793,358 shares (+3059159.7%) to their portfolio in Q4 2025, for an estimated $402,627,018
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,449,490 shares (+174.0%) to their portfolio in Q3 2025, for an estimated $311,134,219
- WELLINGTON MANAGEMENT GROUP LLP removed 744,161 shares (-21.1%) from their portfolio in Q3 2025, for an estimated $94,523,330
- MILLENNIUM MANAGEMENT LLC added 713,738 shares (+140.0%) to their portfolio in Q3 2025, for an estimated $90,659,000
- CITADEL ADVISORS LLC removed 668,742 shares (-68.2%) from their portfolio in Q3 2025, for an estimated $84,943,608
- FMR LLC removed 646,411 shares (-38.0%) from their portfolio in Q3 2025, for an estimated $82,107,125
- 8 KNOTS MANAGEMENT, LLC removed 641,314 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $81,459,704
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Encompass Health Corporation Congressional Stock Trading
Members of Congress have traded $EHC stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $EHC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Encompass Health Corporation Analyst Ratings
Wall Street analysts have issued reports on $EHC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/30/2025
- Keybanc issued a "Overweight" rating on 09/16/2025
- B of A Securities issued a "Buy" rating on 09/10/2025
- Truist Securities issued a "Buy" rating on 08/14/2025
To track analyst ratings and price targets for Encompass Health Corporation, check out Quiver Quantitative's $EHC forecast page.
Encompass Health Corporation Price Targets
Multiple analysts have issued price targets for $EHC recently. We have seen 5 analysts offer price targets for $EHC in the last 6 months, with a median target of $150.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $150.0 on 10/30/2025
- A.J. Rice from UBS set a target price of $150.0 on 10/02/2025
- Matthew Gillmor from Keybanc set a target price of $140.0 on 09/16/2025
- Kevin Fischbeck from B of A Securities set a target price of $160.0 on 09/10/2025
- David Macdonald from Truist Securities set a target price of $140.0 on 08/14/2025
